title: Antihyperalgesic effect of 5-HT7 receptor activation on the midbrain periaqueductal gray in a rat model of neuropathic pain.
abstract: The 5-HT7 receptor is the most recently discovered receptor for 5-hydroxytryptamine (5-HT), and only little is known about the analgesic potential of this receptor. Adenosine triphosphate (ATP) modulates pain transmission by activating P2X/P2Y receptors, in which the P2X3 subtype is an important target for this effect. This study examined the antihyperalgesic effect of the 5-HT7 receptors in the ventrolateral midbrain periaqueductal gray (vlPAG), a crucial site for endogenous pain inhibition. This study also explored the importance of the interactions between the 5-HT7 and P2X3 receptors in this effect. To address this issue, neuropathic pain was induced through chronic constriction injury (CCI) of the sciatic nerve in Sprague-Dawley (SD) rats. The expression level and distribution of the 5-HT7 receptor were evaluated through Western blot and immunohistochemistry. The mechanical withdrawal threshold (MWT) was measured by using an electronic pressure meter test. Different doses (3, 6, and 12μmol) of AS-19, a selective agonist of the 5-HT7 receptor, were administered in the vlPAG of CCI rats. The effects of pretreatment with the selective 5-HT7 receptor antagonist SB-269970 or the selective P2X3 receptor antagonist A-317491 on the analgesic effect of AS-19 were observed. Results showed that CCI decreased the MWT values of the rats. The injury also increased the protein level of the 5-HT7 receptor in the vlPAG of neuropathic pain rats. AS-19 microinjection significantly elevated the MWT values in a dose-dependent manner, but SB-269970 pretreatment attenuated the antihyperalgesic effect of AS-19. Furthermore, the antihyperalgesic effect of the 5-HT7 receptor was partially but significantly blocked by A-317491 pretreatment. These data indicate that the 5-HT7 receptor in the vlPAG exerts an antihyperalgesic effect on rats with neuropathic pain. The 5-HT7 and P2X3 receptors interact in the vlPAG and exhibit an analgesic action through the enhanced function of the endogenous analgesic system.
authors.affiliation: Endocrinology Department, Linyi People's Hospital, Linyi, Shangdong 276000, People's Republic of China.
authors.forename: Shu-Fa
authors.initials: SF
authors.lastname: Li
authors.affiliation: Endocrinology Department, Linyi People's Hospital, Linyi, Shangdong 276000, People's Republic of China.
authors.forename: Yuan-Yuan
authors.initials: YY
authors.lastname: Zhang
authors.affiliation: Zunyi Medical College, Zunyi, Guizhou 563003, People's Republic of China.
authors.forename: You-Yan
authors.initials: YY
authors.lastname: Li
authors.affiliation: Department of Anesthesiology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563003, People's Republic of China.
authors.forename: Song
authors.initials: S
authors.lastname: Wen
authors.affiliation: Research Center for Medicine & Biology, Zunyi Medical College, Zunyi, Guizhou 563003, People's Republic of China. Electronic address: 1643255058@qq.com.
authors.forename: Zhi
authors.initials: Z
authors.lastname: Xiao
mesh_terms: D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D004195:Disease Models, Animal; D006930:Hyperalgesia / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D009437:Neuralgia / Q000188:drug therapy / Q000378:metabolism*; D010147:Pain Measurement / Q000187:drug effects / Q000379:methods; D010487:Periaqueductal Gray / Q000187:drug effects / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D011985:Receptors, Serotonin / Q000378:metabolism*; D013764:Tetrahydronaphthalenes / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: C505862:AS 19 compound; D000700:Analgesics; D011720:Pyrazoles; D011985:Receptors, Serotonin; D013764:Tetrahydronaphthalenes; C104425:serotonin 7 receptor
keywords: 5-HT(7) receptor; Endogenous pain modulatory system; Midbrain periaqueductal gray; Neuropathic pain; P2X(3) receptor